The epidemiology of cirrhosis in the United States a population-based study

Journal of Clinical Gastroenterology

Volumn 49, Issue 8, 2015, Pages 690-696

  Scaglione, Steven ^a,b   Kliethermes, Stephanie ^b   Cao, Guichan ^b   Shoham, David ^b   Durazo, Ramon ^b   Luke, Amy ^b   Volk, Michael L ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Disparities; Mortality; NHANES; Prevalence

Indexed keywords

ASPARTATE AMINOTRANSFERASE;

ADULT; AGE DISTRIBUTION; AGED; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLACK PERSON; CLINICAL FEATURE; DEMOGRAPHY; DIABETES MELLITUS; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HEALTH DISPARITY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; MIDDLE AGED; MORTALITY; POPULATION RESEARCH; POVERTY; PREVALENCE; PRIORITY JOURNAL; PROPENSITY SCORE; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL STATUS; UNITED STATES; AGE; METABOLISM; NUTRITION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; ASPARTATE AMINOTRANSFERASES; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; NUTRITION SURVEYS; POVERTY; PREVALENCE; RISK FACTORS; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84942327052     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000208     Document Type: Article

References (40)

1. Heron M. Deaths: leading causes for 2009. Natl Vital Stat Rep. 2012;61:1-96.
2. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology. 2004;39:476-483.
3. Kim WR, Brown RS Jr, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227-242.
4. Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liverrelated mortality in the United States. Gastroenterology. 2013;145:375-382, e1-2.
5. Davis GL, Alter MJ, El-Serag H, et al. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010;138:513-521, e1-6.
6. Davis GL, Roberts WL. The healthcare burden imposed by liver disease in aging Baby Boomers. Curr Gastroenterol Rep. 2010;12:1-6.
7. Bell BP, Manos MM, Zaman A, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008;103:2727-2736; quiz 2737.
8. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371: 838-851.
9. Graudal N, Leth P, Marbjerg L, et al. Characteristics of cirrhosis undiagnosed during life: a comparative analysis of 73 undiagnosed cases and 149 diagnosed cases of cirrhosis, detected in 4929 consecutive autopsies. J Intern Med. 1991;230: 165-171.
10. Giarelli L, Melato M, Laurino L, et al. Occurrence of liver cirrhosis among autopsies in Trieste. IARC Sci Publ. 1991; 112:37-43.
11. Nguyen GC, Thuluvath PJ. Racial disparity in liver disease: biological, cultural, or socioeconomic factors. Hepatology. 2008;47:1058-1066.
12. Wise M, Bialek S, Finelli L, et al. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology. 2008;47:1128-1135.
13. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
14. Davila JA, El-Serag HB. Racial differences in survival of hepatocellular carcinoma in the United States: a populationbased study. Clin Gastroenterol Hepatol. 2006;4:104-110; quiz 4-5.
15. Guy J, Yee HF Jr. Health disparities in liver disease: time to take notice and take action. Hepatology. 2009;50:309-313.
16. Kadir RA, McLintock C. Thrombocytopenia and disorders of platelet function in pregnancy. Semin Thromb Hemost. 2011;37:640-652.
17. Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518-526.
18. Cales P, Laine F, Boursier J, et al. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol. 2009;50:165-173.
19. Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-Cardenas E, et al. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol. 2008;7:350-357.
20. Lieber CS, Weiss DG, Morgan TR, et al. Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Am J Gastroenterol. 2006;101:1500-1508.
21. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57-63.
22. Heeringa S, West BT, Berglund PA. Applied Survey Data Analysis. Boca Raton, FL: Chapman & Hall/CRC; 2010.
23. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88: 15-19.
24. NCHS. NHANES Analytic and Reporting Guidelines. 2005.
25. US Census Bureau. 2010 Census Briefs: Age and sex composition. Washington, DC: Government Printing Office. Retrieved from http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf.
26. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
27. Hsu CC, Lee CH, Wahlqvist ML, et al. Poverty increases type 2 diabetes incidence and inequality of care despite universal health coverage. Diabetes Care. 2012;35:2286-2292.
28. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300.
29. Baumann M, Spitz E, Guillemin F, et al. Associations of social and material deprivation with tobacco, alcohol, and psychotropic drug use, and gender: a population-based study. Int J Health Geogr. 2007;6:1-12.
30. Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol. 2002;97:700-706.
31. Kallwitz ER, Guzman G, TenCate V, et al. The histologic spectrum of liver disease in African-American, non-Hispanic white, and Hispanic obesity surgery patients. Am J Gastroenterol. 2009;104:64-69.
32. Kohla M, Iwata S, Ea R, et al. Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter? Dig Dis Sci. 2012;57:771-776.
33. Crosse K, Umeadi OG, Anania FA, et al. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol. 2004;2:463-468.
34. Forde KA, Tanapanpanit O, Rajender Reddy K. Hepatitis B and C in African Americans: current status and continued challenges. Clin Gastroenterol Hepatol. 2013;88:15-19.
35. Pearlman BL. Hepatitis C virus infection in African Americans. Clin Infect Dis. 2006;42:82-91.
36. Melia MT, Muir AJ, McCone J, et al. Racial differences in hepatitis C treatment eligibility. Hepatology. 2011;54:70-78.
37. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340: 745-750.
38. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127:S27-S34.
39. Terrault NA, Im K, Boylan R, et al. Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. Clin Gastroenterol Hepatol. 2008;6:1403-1411.
40. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524-530 e1; quiz e60.